sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
22-Jul-2014 03:27
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 426-450 out of 861.

<< < 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 > >>

Public Release: 16-Jul-2013
Research leads to affordable technology to fight mosquito-borne diseases
Technology that hampers mosquitoes' host-seeking behavior, identified at the University of California, Riverside in 2011, has led to the development of the world's first product that blocks mosquitoes' ability to efficiently detect carbon dioxide, their primary method of tracking human blood meals.
Bill and Melinda Gates Foundation, National Institutes of Health

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 12-Jul-2013
PLOS Neglected Tropical Diseases
Exploring gender dimensions of treatment programs for neglected tropical diseases in Uganda
Males and females face different challenges in accessing treatment for neglected tropical diseases, according to a new study from researchers at the University of Toronto Dalla Lana School of Public Health, Uganda Ministry of Health and Imperial College London. The study, published by PLOS Neglected Tropical Diseases on July 11, explores the role of gender in access to treatment in the Uganda National Neglected Tropical Disease Control Program.

Contact: Heather Rilkoff
heather.rilkoff@mail.utoronto.ca
647-206-8328
University of Toronto

Public Release: 11-Jul-2013
Nucleic Acid Therapeutics
New therapeutic strategy targets dengue virus using artificial microRNAs
Mosquito-borne dengue viruses cause an estimated 50 million cases of human dengue fever a year and are a significant public health threat worldwide.

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 11-Jul-2013
3 neglected-disease treatments newly added to WHO Essential Medicines List for paediatric use
This week the World Health Organization (WHO) released its newly updated 4th WHO Model List of Essential Medicines for Children, in which three treatments developed by the Drugs for Neglected Diseases initiative and its partners have now been included. One treatment was also added to the 18th WHO Model List of Essential Medicines for adults.

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 10-Jul-2013
Molecular Biology and Evolution
Malaria in the Americas presents a complex picture
In a new study, Ananias Escalante and an international team explore the genetic diversity of malarial parasite P. vivax in the Americas and other areas of the world. The study shows greater genetic diversity for P. vivax compared with earlier studies and points to plausible routes of malarial introduction into the New World.

Contact: Joseph Caspermeyer
Joseph.Caspermeyer@asu.edu
Arizona State University

Public Release: 10-Jul-2013
University of North Carolina receives $8 million grant to improve safe motherhood in Malawi
The University of North Carolina at Chapel Hill has received a five-year, $8 million grant from the Bill & Melinda Gates Foundation to improve maternal and infant health and save the lives of mothers and infants in Malawi by strengthening the President's Maternal Health and Safe Motherhood Initiative.
Bill & Melinda Gates Foundation

Contact: Lisa Chensvold
lisa_chensvold@med.unc.edu
919-843-5719
University of North Carolina Health Care

Public Release: 10-Jul-2013
Genome Research
Researchers create method to rapidly identify specific strains of illness
Researchers from Boston University School of Medicine and George Washington University have developed a method to rapidly identify pathogenic species and strains causing illnesses, such as pneumonia, that could help lead to earlier detection of disease outbreaks and pinpoint effective treatments more quickly.

Contact: Gina Orlando
gina.orlando@bmc.org
617-638-8490
Boston University Medical Center

Public Release: 9-Jul-2013
PLOS ONE
Bird vaccine for West Nile Virus
University of British Columbia researchers have developed a vaccine to halt the spread of West Nile Virus among common and endangered bird species.

Contact: Brian Lin
brian.lin@ubc.ca
604-822-2234
University of British Columbia

Public Release: 8-Jul-2013
Global Health Corps announces fifth class of fellows
Global Health Corps launched its fifth class of fellows today, during the opening of its annual Training Institute at Yale University. The 106 fellows hail from 16 countries and will serve with 44 health organizations in Burundi, Malawi, Rwanda, Uganda, Zambia and select cities in the United States. The newest fellowship class was selected from a pool of almost 4,000 applicants and highlights GHC's continued growth.

Contact: Anne McPherson
anne@ghcorps.org
917-531-4050
Global Health Strategies

Public Release: 8-Jul-2013
Annals of Internal Medicine
Annals of Internal Medicine tip Sheet for 9 July 2013
Below is information about articles being published in the July 9 issue of Annals of Internal Medicine. The information is not intended to substitute for the full article as a source of information. Annals of Internal Medicine attribution is required for all coverage.

Contact: Megan Hanks
mhanks@acponline.org
215-351-2656
American College of Physicians

Public Release: 3-Jul-2013
Journal of Royal Society Interface
Research team improves immunization strategies for dengue fever in Thailand
Results have implications for designing more effective vaccine studies, says UMass Amherst biostatistician Nicholas Reich, who led the team. Dengue fever is a mosquito-transmitted viral infection that sickens 5 percent of the world's population each year and recently has begun to emerge in parts of the southeast United States. They report the first explicit quantitative evidence that short-term cross-protection exists since human experimental infection studies performed in the 1940s and 1950s by Albert Sabin.
NIH/National Institute of General Medical Sciences, Gates Foundation Vaccine Modeling Initiative

Contact: Janet Lathrop
jlathrop@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst

Public Release: 3-Jul-2013
Science Translational Medicine
Genetic signals reflect the evolutionary impact of cholera
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the Vibrio cholerae bacteria.
National Institutes of Health, Howard Hughes Medical Institute, American Cancer Society, Packard Foundation

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital

Public Release: 2-Jul-2013
Bringing low-cost, inkjet-printed nano test strips to pakistan for drinking water tests
The National Academy of Sciences announced a three-year, $271,930 grant to chemist Vincent Rotello at the University of Massachusetts Amherst to develop, test and deploy new, sensitive, reliable and affordable inkjet-printed, nanoparticle-based test strips for detecting disease-causing bacteria in drinking water, with researchers at the Lahore University of Management Sciences, Pakistan.
US National Academy of Sciences

Contact: Janet Lathrop
jlathrop@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst

Public Release: 1-Jul-2013
New guidelines pave the road for achieving an AIDS-free generation
The Elizabeth Glaser Pediatric AIDS Foundation welcomes the World Health Organization's new HIV/AIDS treatment and prevention guidelines. For the first time, the 2013 guidelines combine recommendations across the continuum of HIV care and prevention programs, including expanding treatment eligibility for HIV-positive pregnant women, mothers, and children. These recommendations signify a major step forward in the global effort to achieve an AIDS-free generation, but will require a significant shift in current implementation efforts.

Contact: Johanna Harvey
jharvey@pedaids.org
202-280-1657
Elizabeth Glaser Pediatric AIDS Foundation

Public Release: 1-Jul-2013
Journal of Clinical Investigation
Cross-species malaria immunity induced by chemically attenuated parasites
In this issue of the Journal of Clinical Investigation, Michael Good and colleagues demonstrate that mice inoculated with a single species of attenuated parasite display immunity to multiple malaria species for over 100 days.
National Health and Medical Research Council Australia Fellowship, Griffith University

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 30-Jun-2013
7th IAS Conference on HIV Pathogenesis, Treatment and Prevention
DNDi and Cipla advance development of pediatric 4-in-1 ARVs to fulfill new WHO guidelines
The World Health Organization's new HIV treatment guidelines, released today at the 2013 International AIDS Society Conference, include new antiretroviral therapy recommendations for HIV-infected children, and will mean that more children will be on better treatments. The Drugs for Neglected Diseases initiative applauds the new guidelines and, with Cipla Ltd. and other partners, is expediting the development of urgently needed 4-in-1 ARVs adapted for babies and toddlers with HIV, to be delivered by 2015.

Contact: Oliver Yun
oyun@dndi.org
646-266-5216
Drugs for Neglected Diseases Initiative

Public Release: 27-Jun-2013
Annals of Biomedical Engineering
Pneumonia revealed in a cough
A new method, which analyzes the sounds in a child's cough, could soon be used in poor, remote regions to diagnose childhood pneumonia reliably. According to Udantha Abeyratne from the University of Queensland in Australia and colleagues, this simple technique of recording coughs with a microphone on the patient's bedside table, has the potential to revolutionize the management of childhood pneumonia. Their work is published online in Springer's journal Annals of Biomedical Engineering.
Bill & Melinda Gates Foundation

Contact: Sophia Grein
sophia.grein@springer.com
49-622-148-78414
Springer

Public Release: 26-Jun-2013
Cell biologist to begin work on discovering structure of malaria parasite genome
Plasmodium, which causes malaria, requires specific human and mosquito tissues to complete its life cycle. The progression and control of this life cycle could be better understood by studying changes of the 3-D structure of the parasite's genome. The University of California, Riverside and the University of Washington have received a four-year grant exceeding $2 million from the National Institutes of Health to discover this 3-D structure of Plasmodium's genome during the parasite's erythrocytic cycle.
National Institutes of Health

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 25-Jun-2013
Oncogene
USC research IDs potential treatment for deadly, HIV-related blood cancer
Researchers at the USC Norris Comprehensive Cancer Center have discovered a promising new way to treat a rare and aggressive blood cancer most commonly found in people infected with HIV.
National Institutes of Health, STOP Cancer Foundation

Contact: Alison Trinidad
alison.trinidad@usc.edu
323-442-3941
University of Southern California - Health Sciences

Public Release: 25-Jun-2013
UW awarded $10 million to design paper-based diagnostic medical device
The University of Washington has received nearly $10 million from the US Department of Defense to continue a project aimed at building a small, paper-based device that could test for infectious diseases on-demand in areas where diagnostic capabilities are limited.

Contact: Michelle Ma
mcma@uw.edu
206-543-2580
University of Washington

Public Release: 25-Jun-2013
Lauren Sciences LLC awarded second Michael J. Fox Foundation grant to further develop V-Smart™ Therapeutic for Parkinson's disease
Lauren Sciences LLC, a privately-held biotechnology company continuing development of its novel V-Smart™ platform technology, announced today the award of a second grant by The Michael J. Fox Foundation for Parkinson's Research (MJFF). The company recently completed the first stage of developing V-Smart™-based therapeutics for the treatment of Parkinson's disease (PD), which was funded by MJFF, whereby it demonstrated targeted delivery of GDNF (glial-derived neurotrophic factor) to brain regions in which neurons degenerate during the course of PD.
The Michael J. Fox Foundation

Contact: Susan Rosenbaum
srosenbaum@laurensciences.com
212-737-0455
Lauren Sciences LLC

Public Release: 24-Jun-2013
Sabin Vaccine Institute launches International Association of Immunization Managers
The Sabin Vaccine Institute today announced the launch of the newly-formed International Association of Immunization Managers. With the support of a five-year grant from the Bill and Melinda Gates Foundation, IAIM's objective is to help drive the achievement of national, regional and international immunization goals, including those in the Global Vaccine Action Plan, by fostering forward-thinking and superior management of immunization programs.
Bill & Melinda Gates Foundation

Contact: Deborah Elson
deborah.elson@sabin.org
202-621-1691
Sabin Vaccine Institute

Public Release: 24-Jun-2013
Malawi trial saves newborn lives
A five-year program that mobilized communities to improve the quality of care for mothers and newborns reduced newborn mortality by 30 percent and saved at least 1,000 newborn lives in rural Malawi.

Contact: Marshall Hoffman
marshall@hoffmanpr.com
703-533-3535
Hoffman & Hoffman Worldwide

Public Release: 24-Jun-2013
Journal of General Physiology
How cholera-causing bacteria respond to pressure
Cholera persists in part because V. cholera, the bacteria that causes the disease, is able to survive in diverse environments ranging from the intestinal lumen, to fresh water, to estuaries, to the sea. A study in The Journal of General Physiology provides new insights about the membrane components of V. cholera that enable it to withstand otherwise deadly increases in osmotic pressure resulting from changes in its surrounding environment.

Contact: Rita Sullivan King
news@rupress.org
212-327-8603
Rockefeller University Press

Public Release: 21-Jun-2013
Stanford's Environmental Ventures Projects program funds 7 new sustainability studies
The 2013 Environmental Venture Projects enable interdisciplinary research studies that propose practical solutions to major sustainability challenges.

Contact: Terry Nagel
tnagel@stanford.edu
650-498-0607
Stanford University

Showing releases 426-450 out of 861.

<< < 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 > >>